Effect of statin therapy on plasma apolipoprotein CIII concentrations: A systematic review and meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Effect of statin therapy on plasma apolipoprotein CIII concentrations: A systematic review and meta-analysis of randomized controlled trials

Published:2018-05 Issue:3 Volume:12 Page:801-809
ISSN:1933-2874
Container-title:Journal of Clinical Lipidology
language:en
Short-container-title:Journal of Clinical Lipidology

Author:

Sahebkar Amirhossein,Simental-Mendía Luis E.,Mikhailidis Dimitri P.,Pirro Matteo,Banach Maciej^ORCID,Sirtori Cesare R.,Ruscica Massimiliano,Reiner Željko

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference59 articles.

1. Efficacy and safety of cholesterol lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins;Baigent;Lancet,2005

2. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials;Mihaylova;Lancet,2012

3. Statins in the primary prevention of cardiovascular disease;Reiner;Nat Rev Cardiol,2013

4. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

5. Association between statin use and plasma d-dimer levels: a systematic review and meta-analysis of randomised controlled trials;Sahebkar;Thromb Haemost,2015

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene profiles and mutations in the development of cataracts in the ICR rat model of hereditary cataracts;Scientific Reports;2023-10-24

2. Influence of rosuvastatin on apolipoproteins and coagulation factor levels: Results from the STAtin Reduce Thrombophilia trial;Research and Practice in Thrombosis and Haemostasis;2023-02

3. Recent Apolipoprotein CIII trials;Current Opinion in Lipidology;2022-09-28

4. High Plasma Concentration of Apolipoprotein C-III Confers an Increased Risk of Cerebral Ischemic Events on Cardiovascular Patients Anticoagulated With Warfarin;Frontiers in Cardiovascular Medicine;2022-02-04

5. Is Apo-CIII the new cardiovascular target? An analysis of its current clinical and dietetic therapies;Nutrition, Metabolism and Cardiovascular Diseases;2022-02